Henry Schein, Inc., based in Melville, has announced that KKR, a leading global investment firm, has made a strategic investment in the company.
Henry Schein is the largest provider in the world of healthcare solutions to dental and medical practices based in offices.
KKR will invest an additional $250 million into Henry Schein, becoming a 12 percent common shareholder. This demonstrates the confidence of the firm in the management team, the company’s BOLD+1 strategy, and the entire company itself. This investment will also enable KKR to purchase additional shares in the open market for a stake of 14.9 percent of the outstanding common shares.
KKR and Henry Schein will collaborate on opportunities to create value for shareholders and move the company into its next growth phase. The focus will be on operational excellence, employee engagement, strategic growth, and capital allocation.
News of such investments and their benefits for a company are often made known throughout the community with flyer printing.
As part of this investment, William Daniel and Max Lin will join the Board of Directors of Henry Schein as independent directors. Chief Executive Officer and Chairman of the Board of Henry Schein, Stanley M. Bergman, said that the management team and the board have great respect for KKR. He added that KKR has an approach that is oriented towards partnerships as well as experience in supporting the creation of values across its investments.
